| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Tarsus Pharmaceuticals, Inc. (TARS) has 12 insiders with recent SEC Form 4 filings, including 1 buy and 12 sells. TARS is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 858.5K | $52.55M | - | |
| Dir | 128.8K | $7.89M | - | |
| COO | 79.2K | $4.85M | - | |
| Other | 47.6K | $2.91M | - | |
| Other | 36.7K | $2.25M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 30, 2023 | Wahl Bryan | General Counsel | Sale+OE | 8,356 | $16.31 | $136,286.36 | -20.7% | +129.1% | +217.3% | |
| Nov 15, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $18.37 | $146,933.12 | -0.3% | +65.4% | +160.2% | |
| Oct 18, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $13.24 | $105,920.00 | -0.9% | +70.0% | +178.7% | |
| Oct 5, 2023 | Trevejo Jose M. | Chief Medical Officer | Sell | 1,604 | $18.00 | $28,872.00 | -26.3% | +7.9% | +83.0% | |
| Sep 20, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $17.21 | $137,680.00 | -0.9% | +14.3% | +106.6% | |
| Aug 23, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 8,000 | $17.23 | $137,840.00 | -0.9% | +1.3% | +45.9% | |
| Aug 15, 2023 | Lin Elizabeth Yeu | Director | Buy | 9,506 | $16.80 | $159,700.80 | +149.5% | +1.0% | +56.8% | |
| Jul 19, 2023 | Mottiwala Aziz51 | Chief Commercial Officer | Sell | 2,400 | $20.05 | $48,120.00 | -5.0% | -33.3% | +35.5% | |
| Jul 19, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 103,900 | $20.01 | $2,078,983.76 | -5.1% | -33.3% | +35.5% | |
| Jul 12, 2023 | Azamian Bobak R.45 | President/ CEO And Board Chair | Sell | 9,000 | $17.35 | $156,150.00 | -0.9% | -4.6% | +73.1% |